Trisomy 12 is a Rare Event in Cases of CLL with Typical Immunophenotype and Morphology

References

• Matutes, E. (1996). Trisomy 12 in chronic lymphocytic leukemia. Leukemia Res., 20, 375–77.
   PubMed Web of Science ®Google Scholar
• Bird, M. L., Ueshima, Y., Rowley, J. D., Haren, J. M. and Vardiman, J. W. (1989). Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations. Leukemia, 3, 182–91.
   PubMed Web of Science ®Google Scholar
• Que, T. H., Garcia Marco, J., Ellis, J., Matutes, E., Brito Babapulle, V., Boyle, S. and Catovsky, D. (1993). Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. Blood, 82, 571–75.
   PubMed Web of Science ®Google Scholar
• Criel, A., Wlodarska, I., Meeus, P., Stul, M., Louwagie, A., Van Hoof, A., Hidajat, M., Mecucci, C. and Van Den Berghe, H. (1994). Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias. Brit. J. Haematol., 87, 523–28.
   PubMed Web of Science ®Google Scholar
• Criel, A., Verhoef, G., Vlietinck, R., Mecucci, C., Billiet, J., Michaux, L., Meeus, P., Louwagie, A., Van Orshoven, A., Van Hoof, A., Boogaerts, M., Van Den Berghe, H. and De Wolf-Peeters, C. (1997). Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. Brit. J. Haematol., 97, 383–91.
   PubMed Web of Science ®Google Scholar
• Matutes, E., Oscier, D., Garcia-Marco, J., Ellis, J., Copplestone, A., Gillingham, R., Hamblin, T., Lens, D., Swansbury, G. J. and Catovsky, D. (1996). Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Brit. J. Haematol., 92, 382–88.
   PubMed Web of Science ®Google Scholar
• Cabanillas, F., Trujillo, J. M., Barlogie, B., McLaughlin, P., Cork, A., Butler, J. J., Manning, J. T. and Riggs, S. A. (1986). Chromosomal abnormalities in lymphoma and their correlations with nucleic acid flow cytometry. Cancer Genet, and Cytogenet., 21, 99–106.
   PubMed Web of Science ®Google Scholar
• Offit, K., Jhanwar, S. C., Ladanyi, M., Filippa, D. A. and Chaganti, R. S. K. (1991). Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's Lymphoma: Correlations between recurrent aberrations, histology and exposure to cytotoxic treatment. Genes, Chromosomes and Cancer, 3, 189–201.
   PubMed Web of Science ®Google Scholar
• Cabanillas, F., Pathak, S., Trujillo, J., Manning, J., Katz, R., McLaughlin, P., Velasquez, W. S., Hagemeister, F. B., Goodacre, A., Cork, A., Butler, J. J. and Freireich, E. J. (1988). Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma. Cancer Res., 48, 5557–64.
   PubMed Web of Science ®Google Scholar
• Matutes, E. and Catovsky, D. (1991). The classification of lymphoid leukaemias. Leuk. Lymphoma, 5 (suppl.) 153–5.
   PubMed Web of Science ®Google Scholar
• Bennett, J. M., Catovsky, D., Daniel, M.-T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1989). Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J. Clin. Pathol., 42, 567–84.
   PubMed Web of Science ®Google Scholar
• Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia-Marco, J., Houlihan, A., Que, T. H. and Catovsky, D. (1994). The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia, 8, 1640–5.
   PubMed Web of Science ®Google Scholar
• Cano, I., Martinez, J., Quevedo, E., Pinilla, J., Martin-Recio, A., Rodridguez, A., Castañeda, A., López, R., Pérez-Piño, T. and Hernández-Navarro, F. (1996). Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Association with morphology and resistance to conventional chemotherapy. Cancer. Genet. and Cytogenet., 90, 118–24.
   PubMed Web of Science ®Google Scholar
• Juliusson, G. and Gahrton, G. (1985). Abnormal/normal metaphase ratio and prognosis in chronic B-lymphocytic leukemia. Cancer. Genet, and Cytogenet., 18, 307–13.
   PubMed Web of Science ®Google Scholar
• Gahrton, G. and Juliusson, G. (1988). Clinical implication of chromosomal abberations in chronic B-lymphocytic leukaemic cells. Nouv. Rev. Fr. Hematol., 30, 389–92.
   PubMedGoogle Scholar
• Han, T., Sadamori, N., Block, A. M. W., Xiao, H., Henderson, E. S., Emrich, L. and Sandberg, A. A. (1988). Cytogenetic studies in chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia a progress report. Nouv. Rev. Fr. Hematol., 30, 393–5.
   PubMedGoogle Scholar
• Oscier, D. G., Fitchett, M. and Hamblin, T. J. (1988). Chromosomal abnormalities in B-CLL. Nouv. Rev. Fr. Hematol., 30, 397–8.
   PubMedGoogle Scholar
• Daniel, M.-T., Tigaud, I., Flexor, M.-A., Nogueira, M.-E., Berger, R. and Jonveaux, P. (1995). Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t (11; 14) (q13; q32): a subtype of mantle cell lymphoma? Brit. J. Haem., 90, 77–84.
   PubMed Web of Science ®Google Scholar
• Gribben, J. G., Freedman, A. S., Woo, S. D., Blake, K., Shu, R. S., Freeman, G., Longtine, J. A., Pinkus, G. S. and Nadler, L. M. (1991). All advanced stage Non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood, 78, 3275–80.
   PubMed Web of Science ®Google Scholar
• Wan, J. H., Trainor, K. J., Brisco, M. J. and Morley, A. A. (1990). Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. j. Clin. Path., 43, 888–90.
   PubMed Web of Science ®Google Scholar
• Williams, M. E., Swerdlow, S. H. and Meeker, T. C. (1993). Chromosome t (11; 14) (q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia, 7, 1437–40.
   PubMed Web of Science ®Google Scholar
• Zomas, A. P., Matutes, E., Morilla, R., Owusu-Ankomah, K., Seon, B. K. and Catovsky, D. (1996). Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia, 10, 1966–70.
   PubMed Web of Science ®Google Scholar
• Yunis, J. J., Frizzera, G., Oken, M. M., McKenna, J., Theologides, A. and Amesen, M. (1987). Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N. Engl. J. Med., 316, 79–84.
   PubMed Web of Science ®Google Scholar
• Neilson, J. R., Cai, M., Bienz, N. and Leyland, M. J. (1995). Leukaemic mantle cell lymphoma with t (11; 14) and trisomy 12 showing clinical features of stage A0 B cell chronic lymphocytic leukaemia. J. Clin. Pathol: Mol. Pathol., 48, M165–6.
   Google Scholar
• Neilson, J. R., Fegan, C. D. and Milligan, D. W. (1996). Mantle cell leukaemia? Brit. J. Haem., 93, 494–5.
   PubMed Web of Science ®Google Scholar
• Weisenburger, D. D. and Armitage, J. O. (1996). Mantle cell lymphoma—An entity comes of age. Blood, 87, 4483–94.
   PubMed Web of Science ®Google Scholar
• Geisler, C. H., Philip, P., Egelund Christensen, B., HouJensen, K., Tinggaard Pedersen, N., Myhre Jensen, O., Thorling, K., Andersen, E., Birgens, H., Nielsen, H., Ellegaard, J., Larsen, J. K., Brown, P., Kragh Andersen, P. and Mørk Hansen, M. (1997). Trisomy 12 is found in CLL with both typical and atypical immunophenotype and has no prognostic significance. Proceedings of VII International Workshop on CLL, Crete, Abstract 013.
   Google Scholar